ChemoCentryx
CCXI
#3578
Rank
โ‚น346.50 B
Marketcap
โ‚น4,818
Share price
0.00%
Change (1 day)
39.72%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): -โ‚น143.43

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is -โ‚น175.15. In 2021 the company made an earnings per share (EPS) of -โ‚น175.15 a decrease over its 2020 EPS that were of -โ‚น75.06.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-โ‚น143.43-18.11%
2021-โ‚น175.15133.33%
2020-โ‚น75.06-16.49%
2019-โ‚น89.8927.63%
2018-โ‚น70.43-305.41%
2017โ‚น34.29-142.53%
2016-โ‚น80.62-19.44%
2015-โ‚น100.08-0%
2014-โ‚น100.0813.68%
2013-โ‚น88.04-16.67%
2012-โ‚น105.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น619.02-453.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น65.80-137.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น542.27-409.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,611-1,019.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น218.70-224.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น92.03-152.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น418.87-339.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น266.64-252.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น41.70-123.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel